$ cat ./records/gates-foundation-commits-50-million-to-west-africa-ebola-emergenc-2014.txt
Gates Foundation Commits $50 Million to West Africa Ebola Emergency Response
[RECORD.TXT] · cat --full
As the 2014 West Africa Ebola outbreak spiralled into the deadliest in history — eventually killing more than 11,000 people across Guinea, Liberia, and Sierra Leone — the Gates Foundation committed $50 million to scale up the emergency response, on top of $10 million already disbursed. Funds were directed to WHO for emergency operations and vaccine R&D acceleration, UNICEF for support in affected countries, and CDC for incident management. The foundation also mobilised its private-sector networks to expedite diagnostic, therapeutic, and vaccine development pipelines.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Backs Sabin Vaccine Institute to Develop ChAd3 Ebola Vaccine
Next →
Gates Foundation Commits $40 Million to Diarrheal Disease Vaccine Development
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.